Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Change in Receivables (2016 - 2025)

Innospec's Change in Receivables history spans 16 years, with the latest figure at -$6.9 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 123.63% year-over-year to -$6.9 million; the TTM value through Dec 2025 reached -$21.6 million, down 402.33%, while the annual FY2025 figure was -$21.6 million, 402.33% down from the prior year.
  • Change in Receivables for Q4 2025 was -$6.9 million at Innospec, down from $14.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $52.9 million in Q1 2022 and bottomed at -$39.5 million in Q1 2024.
  • The 5-year median for Change in Receivables is $7.0 million (2022), against an average of $5.6 million.
  • The largest YoY upside for Change in Receivables was 777.42% in 2024 against a maximum downside of 758.33% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$16.2 million in 2021, then increased by 9.88% to -$14.6 million in 2022, then skyrocketed by 388.36% to $42.1 million in 2023, then plummeted by 30.64% to $29.2 million in 2024, then crashed by 123.63% to -$6.9 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Change in Receivables are -$6.9 million (Q4 2025), $14.2 million (Q3 2025), and -$22.3 million (Q2 2025).